Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study

Authors: Kingsley Lezor Bieh, Ralf Weigel, Helen Smith

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

In Nigeria multidrug-resistant tuberculosis (MDR-TB) is prevalent in 2.9% of new TB cases and 14% of retreatment cases, and the country is one of 27 with high disease burden globally. Patients are admitted and confined to one of ten MDR-TB treatment facilities throughout the initial 8 months of treatment. The perspectives of MDR-TB patients shared on social media and in academic research and those of providers are limited to experiences of home-based care. In this study we explored the views of hospitalised MDR-TB patients and providers in one treatment facility in Nigeria, and describe how their experiences are linked to accessibility of care and support services, in line with international goals. We aimed to explore the physical, social and psychological needs of hospitalized MDR TB patients, examine providers’ perceptions about the hospital based model and discuss the model’s advantages and disadvantages from the patient and the provider perspective.

Methods

We conducted two gender distinct focus group discussions and 11 in-depth interviews with recently discharged MDR-TB patients from one MDR-TB treatment facility in Nigeria. We triangulated this with the views of four providers who played key roles in the management of MDR-TB patients via key informant interviews. Transcribed data was thematically analysed, using an iterative process to constantly compare and contrast emerging themes across the data set for deeper understanding of the full range of participants’ views.

Results

The study findings demonstrate the psycho-social impacts of prolonged isolation and the coping mechanisms of patients in the facility. The dislocation of patients from their normal social networks and the detachment between providers and patients created the need for interdependence of patients for emotional and physical support. Providers’ fears of infection contributed to stigma and hindered accessibility of care and support services.

Conclusion

The current trend towards discharging patients after culture conversion would reduce the psycho-social impacts of prolonged isolation and potentially reduce the risk of occupational TB from prolonged contact with MDR-TB patients. Building on shared experiences and interdependence of MDR-TB patients in our study, innovative patient-centred support systems would likely help to reduce stigma, promote access to care and support services, and potentially impact on the outcome of treatment.
Literature
1.
go back to reference World Health Organization. Global Tuberculosis Report 2014. Geneva: World Health Organization; 2014. World Health Organization. Global Tuberculosis Report 2014. Geneva: World Health Organization; 2014.
2.
go back to reference Falzon D, Jaramillo E, Wares F, Zignol M, Floyd K, Raviglione MC. Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. Lancet Infect Dis. 2013;13(8):690–7.CrossRefPubMed Falzon D, Jaramillo E, Wares F, Zignol M, Floyd K, Raviglione MC. Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. Lancet Infect Dis. 2013;13(8):690–7.CrossRefPubMed
3.
go back to reference World Health Organization. Towards universal access to diagnosis and treatment of multi-drug resistant Tuberculosis:WHO progress report 2011. Geneva: WHO; 2011. World Health Organization. Towards universal access to diagnosis and treatment of multi-drug resistant Tuberculosis:WHO progress report 2011. Geneva: WHO; 2011.
4.
go back to reference World Health Organization. Global tuberculosis report 2015. 2015. World Health Organization. Global tuberculosis report 2015. 2015.
5.
go back to reference World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis 2016 update. 2016. World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis 2016 update. 2016.
6.
go back to reference World Health Organization. Guidelines for the programmatic management of drug resistant Tuberculosis 2011 update. Geneva: WHO; 2011. World Health Organization. Guidelines for the programmatic management of drug resistant Tuberculosis 2011 update. Geneva: WHO; 2011.
7.
go back to reference NTBLCP. Guidelines for the clinical management and control of drug resistant Tuberculosis in Nigeria. Abuja: National Tuberculosis and Leprosy Control Programme; 2011. NTBLCP. Guidelines for the clinical management and control of drug resistant Tuberculosis in Nigeria. Abuja: National Tuberculosis and Leprosy Control Programme; 2011.
8.
go back to reference Oladimeji O, Isaakidis P, Obasanya OJ, Eltayeb O, Khogali M, Van den Bergh R, et al. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria. PLoS ONE. 2014;9(4):e94393.CrossRefPubMedPubMedCentral Oladimeji O, Isaakidis P, Obasanya OJ, Eltayeb O, Khogali M, Van den Bergh R, et al. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria. PLoS ONE. 2014;9(4):e94393.CrossRefPubMedPubMedCentral
9.
go back to reference Isaakidis P, Rangan S, Pradhan A, Ladomirska J, Reid T, Kielmann K. ‘I cry every day’: experiences of patients co-infected with HIV and multidrug-resistant tuberculosis. Trop Med Int Health. 2013;18(9):1128–33.CrossRefPubMed Isaakidis P, Rangan S, Pradhan A, Ladomirska J, Reid T, Kielmann K. ‘I cry every day’: experiences of patients co-infected with HIV and multidrug-resistant tuberculosis. Trop Med Int Health. 2013;18(9):1128–33.CrossRefPubMed
10.
go back to reference Horter S, Stringer B, Reynolds L, Shoaib M, Kasozi S, Casas EC, et al. “Home is where the patient is”: a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis. BMC Health Serv Res. 2014;14(1):1–8.CrossRef Horter S, Stringer B, Reynolds L, Shoaib M, Kasozi S, Casas EC, et al. “Home is where the patient is”: a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis. BMC Health Serv Res. 2014;14(1):1–8.CrossRef
11.
go back to reference Morris MD, Quezada L, Bhat P, Moser K, Smith J, Perez H, et al. Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient’s perspective. Int J Tuberc Lung Dis. 2013;17(7):954–60.CrossRefPubMedPubMedCentral Morris MD, Quezada L, Bhat P, Moser K, Smith J, Perez H, et al. Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient’s perspective. Int J Tuberc Lung Dis. 2013;17(7):954–60.CrossRefPubMedPubMedCentral
12.
go back to reference Shin S, Furin J, Bayona J, Mate K, Kim JY, Farmer P. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc Sci Med. 2004;59(7):1529–39.CrossRefPubMed Shin S, Furin J, Bayona J, Mate K, Kim JY, Farmer P. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc Sci Med. 2004;59(7):1529–39.CrossRefPubMed
13.
go back to reference Brust JC, Shah NS, Scott M, Chaiyachati K, Lygizos M, van der Merwe TL, et al. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. Int J Tuberc Lung Dis. 2012;16(8):998–1004.CrossRefPubMedPubMedCentral Brust JC, Shah NS, Scott M, Chaiyachati K, Lygizos M, van der Merwe TL, et al. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. Int J Tuberc Lung Dis. 2012;16(8):998–1004.CrossRefPubMedPubMedCentral
14.
go back to reference Nathanson E, Nunn P, Uplekar M, Floyd K, Jaramillo E, Lönnroth K, et al. MDR tuberculosis—critical steps for prevention and control. N Engl J Med. 2010;363(11):1050–8.CrossRefPubMed Nathanson E, Nunn P, Uplekar M, Floyd K, Jaramillo E, Lönnroth K, et al. MDR tuberculosis—critical steps for prevention and control. N Engl J Med. 2010;363(11):1050–8.CrossRefPubMed
15.
go back to reference Horter S, Stringer B, Venis S, du Cros P. “I Can Also Serve as an Inspiration”: A Qualitative Study of the TB&Me Blogging Experience and Its Role in MDR-TB Treatment. PLoS ONE. 2014;9(9):e108591.CrossRefPubMedPubMedCentral Horter S, Stringer B, Venis S, du Cros P. “I Can Also Serve as an Inspiration”: A Qualitative Study of the TB&Me Blogging Experience and Its Role in MDR-TB Treatment. PLoS ONE. 2014;9(9):e108591.CrossRefPubMedPubMedCentral
16.
go back to reference Bassili A, Fitzpatrick C, Qadeer E, Fatima R, Floyd K, Jaramillo E. A Systematic Review of the Effectiveness of Hospital-and Ambulatory-Based Management of Multidrug-Resistant Tuberculosis. AmJTrop Med Hyg. 2013;89(2):271–80.CrossRef Bassili A, Fitzpatrick C, Qadeer E, Fatima R, Floyd K, Jaramillo E. A Systematic Review of the Effectiveness of Hospital-and Ambulatory-Based Management of Multidrug-Resistant Tuberculosis. AmJTrop Med Hyg. 2013;89(2):271–80.CrossRef
17.
go back to reference Ritchie J, Lewis J, Nicholls CM, Ormston R. Qualitative research practice: A guide for social science students and researchers. Sage; 2013. Ritchie J, Lewis J, Nicholls CM, Ormston R. Qualitative research practice: A guide for social science students and researchers. Sage; 2013.
18.
go back to reference Welsh E. Dealing with data: Using NVivo in the qualitative data analysis process. In: Forum Qualitative Sozialforschung/Forum: Qualitative Social Research. 2002. Welsh E. Dealing with data: Using NVivo in the qualitative data analysis process. In: Forum Qualitative Sozialforschung/Forum: Qualitative Social Research. 2002.
19.
go back to reference Baral SC, Newell JN, Karki DK. Causes of stigma and discrimination associated with tuberculosis in Nepal: A qualitative study. BMC Public Health. 2007;7:1.CrossRef Baral SC, Newell JN, Karki DK. Causes of stigma and discrimination associated with tuberculosis in Nepal: A qualitative study. BMC Public Health. 2007;7:1.CrossRef
21.
go back to reference Von Delft A, Dramowski A, Khosa C, Kotze K, Lederer P, Mosidi T, et al. Why healthcare workers are sick of TB. Int J Infect Dis. 2015;32:147–51.CrossRef Von Delft A, Dramowski A, Khosa C, Kotze K, Lederer P, Mosidi T, et al. Why healthcare workers are sick of TB. Int J Infect Dis. 2015;32:147–51.CrossRef
22.
go back to reference DeVeaux MI. Trauma of the Incarceration Experience, The. Harv CR-CLL Rev. 2013;48:257. DeVeaux MI. Trauma of the Incarceration Experience, The. Harv CR-CLL Rev. 2013;48:257.
23.
go back to reference Haney C. The psychological impact of incarceration: Implications for post-prison adjustment, Prisoners once removed: The impact of incarceration and reentry on children, families, and communities, vol. 33. 2003. p. 66. Haney C. The psychological impact of incarceration: Implications for post-prison adjustment, Prisoners once removed: The impact of incarceration and reentry on children, families, and communities, vol. 33. 2003. p. 66.
24.
go back to reference Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603–62.CrossRefPubMed Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603–62.CrossRefPubMed
25.
go back to reference Chalco K, Wu DY, Mestanza L, Munoz M, Llaro K, Guerra D, et al. Nurses as providers of emotional support to patients with MDR-TB. Int Nurs Rev. 2006;53(4):253–60.CrossRefPubMed Chalco K, Wu DY, Mestanza L, Munoz M, Llaro K, Guerra D, et al. Nurses as providers of emotional support to patients with MDR-TB. Int Nurs Rev. 2006;53(4):253–60.CrossRefPubMed
26.
go back to reference Mulemi BA. Patients’ perspectives on hospitalisation: Experiences from a cancer ward in Kenya. Anthropol Med. 2008;15(2):117–31.CrossRefPubMed Mulemi BA. Patients’ perspectives on hospitalisation: Experiences from a cancer ward in Kenya. Anthropol Med. 2008;15(2):117–31.CrossRefPubMed
27.
go back to reference Goffman E. Stigma. Notes on the Management of Spoiled Identity. New York: Simon and Shuster; 1963. Inc. Goffman E. Stigma. Notes on the Management of Spoiled Identity. New York: Simon and Shuster; 1963. Inc.
28.
go back to reference Dharmadhikari AS, Mphahlele M, Venter K, Stoltz A, Mathebula R, Masotla T, et al. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014;18(9):1019–25.CrossRefPubMedPubMedCentral Dharmadhikari AS, Mphahlele M, Venter K, Stoltz A, Mathebula R, Masotla T, et al. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014;18(9):1019–25.CrossRefPubMedPubMedCentral
29.
go back to reference Sinanovic E, Ramma L, Vassall A, Azevedo V, Wilkinson L, Ndjeka N, et al. Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa. Int J Tuberc Lung Dis. 2015;19(2):172–8.CrossRefPubMedPubMedCentral Sinanovic E, Ramma L, Vassall A, Azevedo V, Wilkinson L, Ndjeka N, et al. Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa. Int J Tuberc Lung Dis. 2015;19(2):172–8.CrossRefPubMedPubMedCentral
Metadata
Title
Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study
Authors
Kingsley Lezor Bieh
Ralf Weigel
Helen Smith
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-2114-x

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue